JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
GeneDx Holdings
WGS
$2.18B
| $8.29M | ﹤0.01% |
107,891
+55,730
| +107% | +$3.89M |
2021 Q4
12 quarters
|
|
2802
JPMorgan Active China ETF
JCHI
$13.9M
| $8.29M | ﹤0.01% |
190,000
-10,000
| -5% | -$464K |
2023 Q1
7 quarters
|
|
2803
PUT
Pultegroup
PHM
$22B
| $8.27M | ﹤0.01% |
75,900
| – | – |
2023 Q2
6 quarters
|
|
2804
PUT
Suncor Energy
SU
$81.4B
| $8.25M | ﹤0.01% |
231,200
+100,000
| +76% | +$3.85M |
2023 Q4
4 quarters
|
|
|
STR
2805
DELISTED
Sitio Royalties
STR
| $8.24M | ﹤0.01% |
429,561
+172,819
| +67% | +$3.86M |
2019 Q1
23 quarters
|
|
|
SWTX
2806
DELISTED
SpringWorks Therapeutics
SWTX
| $8.24M | ﹤0.01% |
227,935
-27,117
| -11% | -$947K |
2019 Q4
20 quarters
|
|
2807
Ooma
OOMA
$574M
| $8.23M | ﹤0.01% |
585,020
-11,582
| -2% | -$154K |
2017 Q3
29 quarters
|
|
2808
BridgeBio Pharma
BBIO
$13.1B
| $8.21M | ﹤0.01% |
299,214
-916,902
| -75% | -$23.7M |
2019 Q2
22 quarters
|
|
2809
SunCoke Energy
SXC
$840M
| $8.21M | ﹤0.01% |
767,098
-84,953
| -10% | -$910K |
2013 Q2
46 quarters
|
|
2810
Central Garden & Pet Co Class A
CENTA
$2.15B
| $8.2M | ﹤0.01% |
248,207
+37,393
| +18% | +$1.19M |
2013 Q2
46 quarters
|
|
2811
CALL
Toll Brothers
TOL
$12.6B
| $8.2M | ﹤0.01% |
65,100
| – | – |
2024 Q2
2 quarters
|
|
|
AHRT
2812
AH Realty Trust
AHRT
$450M
| $8.2M | ﹤0.01% |
801,274
+179,179
| +29% | +$1.95M |
2014 Q2
42 quarters
|
|
2813
Lazard
LAZ
$3.52B
| $8.16M | ﹤0.01% |
158,604
-30,641
| -16% | -$1.64M |
2013 Q2
46 quarters
|
|
2814
Main Street Capital
MAIN
$5.15B
| $8.15M | ﹤0.01% |
139,189
+37,640
| +37% | +$2.01M |
2015 Q4
36 quarters
|
|
2815
PUT
Abercrombie & Fitch
ANF
$5.77B
| $8.15M | ﹤0.01% |
54,500
+54,000
| +10,800% | +$7.89M |
2024 Q2
2 quarters
|
|
2816
Healthcare Services Group
HCSG
$1.43B
| $8.14M | ﹤0.01% |
700,651
-72,984
| -9% | -$832K |
2013 Q2
46 quarters
|
|
2817
Euronet Worldwide
EEFT
$2.38B
| $8.13M | ﹤0.01% |
79,092
+8,174
| +12% | +$832K |
2015 Q1
39 quarters
|
|
2818
Radware
RDWR
$1.29B
| $8.12M | ﹤0.01% |
360,375
+31,396
| +10% | +$719K |
2016 Q1
35 quarters
|
|
2819
Skyward Specialty Insurance
SKWD
$2.44B
| $8.12M | ﹤0.01% |
160,647
+74,345
| +86% | +$3.61M |
2023 Q1
7 quarters
|
|
2820
Harmony Biosciences
HRMY
$2.31B
| $8.12M | ﹤0.01% |
235,882
+5,454
| +2% | +$187K |
2020 Q3
17 quarters
|
|
2821
CALL
Teck Resources
TECK
$33.6B
| $8.11M | ﹤0.01% |
200,000
| – | – |
2024 Q3
1 quarter
|
|
2822
Intercorp Financial Services
IFS
$5.86B
| $8.11M | ﹤0.01% |
276,275
-12,020
| -4% | -$335K |
2019 Q3
21 quarters
|
|
2823
Kyverna Therapeutics
KYTX
$385M
| $8.1M | ﹤0.01% |
2,166,437
-220,915
| -9% | -$1.06M |
2024 Q1
3 quarters
|
|
2824
PUT
Chewy
CHWY
$7.3B
| $8.1M | ﹤0.01% |
241,900
+600
| +0.2% | +$18.7K |
2021 Q4
12 quarters
|
|
2825
Capital Group Municipal Income ETF
CGMU
$6.68B
| $8.1M | ﹤0.01% |
300,740
-809,782
| -73% | -$22M |
2024 Q2
2 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.